Akums Drugs and Pharmaceuticals Limited
| Opening Date | Closing Date | Face Value | Issue Price | Lot Size | Listing At | Total Issue Size | Basis of Allotment | Initiation of Refunds | Credit of Shares to Demat | Listing Date |
|---|---|---|---|---|---|---|---|---|---|---|
| 29-07-2024 | 31-07-2024 | 2 | 679 | 22 Shares | BSE, NSEBSE, NSE | 17,330,435 shares of ₹2 (aggregating up to ₹1,262.83 Cr) | 2024-08-04 18:30:00 | 2024-08-04 18:30:00 | 2024-08-04 18:30:00 | 05-08-2024 |
About The Company
Akums Drugs and Pharmaceuticals IPO is a book built issue of Rs 1,856.74 crores. The issue is a combination of fresh issue of 1 crore shares aggregating to Rs 680.00 crores and offer for sale of 1.73 crore shares aggregating to Rs 1,262.83 crores.
Akums Drugs and Pharmaceuticals IPO opens for subscription on July 30, 2024 and closes on August 1, 2024. The allotment for the Akums Drugs and Pharmaceuticals IPO is expected to be finalized on Friday, August 2, 2024. Akums Drugs and Pharmaceuticals IPO will list on BSE, NSE with tentative listing date fixed as Tuesday, August 6, 2024.
Akums Drugs and Pharmaceuticals IPO price band is set at ₹646 to ₹679 per share. The minimum lot size for an application is 22 Shares. The minimum amount of investment required by retail investors is ₹14,938. The minimum lot size investment for sNII is 14 lots (308 shares), amounting to ₹209,132, and for bNII, it is 67 lots (1,474 shares), amounting to ₹1,000,846.
ICICI Securities Limited, Axis Bank Limited, Citigroup Global Markets India Private Limited and Ambit Private Limited are the book running lead managers of the Akums Drugs and Pharmaceuticals IPO, while Link Intime India Private Ltd is the registrar for the issue.
Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|
| 30-03-2024 | 3516 | 4212 | 1 | 709.5 | 709.5 | 491.56 |
| 30-03-2023 | 3267 | 3701 | 98 | 717.19 | 868.7 | 536.97 |
| 30-03-2022 | 3069 | 3695 | -251 | 621.98 | 787.79 | 357.95 |
IPO Subscription Status
| Category | Subscription Times |
|---|---|
| Anchor Investors | 1 |
| Qualified Institutions | 90.09 |
| Non-Institutional Buyers | 42.10 |
| Retail Investors | 20.80 |
| Employees | 4.14 |
| Total | 63.44 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | 14938 |
| Retail (Max) | 13 | 286 | 194194 |
| S-HNI (Min) | 14 | 308 | 209132 |
| S-HNI (Max) | 66 | 1452 | 985908 |
| B-HNI (Min) | 67 | 1474 | 10008846 |
IPO Listing Details
| Listing Date | 05-08-2024 |
| BSE Script Code | 544222 |
| NSE Symbol | AKUMS |
| ISIN | INE09XN01023 |
| Final Issue Price | 679 |
Promoter holdings
Sanjeev Jain, Sandeep Jain, and Akums Master Trust are the company's promoters.
Contact Information of the Company
Akums Drugs and Pharmaceuticals Limited
304, Mohan Place,
LSC Saraswati Vihar,
Delhi - 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in/
IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: akumsdrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
IPO Lead Manager
ICICI Securities Limited (Past IPO Performance) Axis Bank Limited (Past IPO Performance) Citigroup Global Markets India Private Limited (Past IPO Performance) Ambit Private Limited (Past IPO Performance)